Sanofi India Board Proposes ₹48 Dividend, Secures AGM Date and New Director

Sanofi India's Board of Directors met on March 25, 2026, approving key corporate actions. The board recommended a final dividend of ₹48 per equity share for the financial year ended December 31, 2025, and appointed Mr. Siraj Azmat Chaudhry as an Additional and Independent Director for a term of five years, effective April 1, 2026. The company also approved the scheduling of its 70th Annual General Meeting (AGM) for April 29, 2026. Both the proposed dividend payout and Mr. Chaudhry's directorship are contingent upon receiving formal approval from shareholders at the upcoming AGM.

Dividend and Director Appointments Await Shareholder Vote

Shareholders will cast their votes on these significant proposals at the 70th AGM. The recommended final dividend of ₹48 per share for FY2025 is notably lower than the ₹117 per share dividend recommended for FY2024. Mr. Chaudhry's appointment, effective April 1, 2026, is set to enhance the board's oversight and governance structure for a five-year term.

Company Context and Competitive Environment

Sanofi India, a prominent multinational pharmaceutical company and subsidiary of the global healthcare giant Sanofi, operates across key therapeutic areas. The company has a history of rewarding shareholders, though the current dividend recommendation marks a shift from previous payouts.

In the competitive Indian pharmaceutical market, Sanofi India vies with major players like Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., and Cipla Ltd. These companies focus on research and development, new product launches, and market expansion, alongside shareholder returns.

Key Risks for Investors

The primary risk for investors lies in the outcome of the shareholder vote at the AGM. Failure to secure approval could prevent the dividend distribution and the new director's formal appointment. The substantial difference in the recommended dividend amount compared to the previous year may also be a point of investor discussion.

What to Watch Next

Investors will closely monitor the proceedings of the 70th AGM on April 29, 2026. Following shareholder ratification, attention will turn to the formal confirmation and payment schedule for the dividend, as well as Mr. Chaudhry's integration and contributions to the board's strategic decisions.